These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 27144279)
41. Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests. Jean SS; Hsieh TC; Hsu CW; Lee WS; Bai KJ; Lam C J Microbiol Immunol Infect; 2016 Dec; 49(6):924-933. PubMed ID: 26341302 [TBL] [Abstract][Full Text] [Related]
42. Safety and efficacy of intravenous tigecycline in subjects with secondary bacteremia: pooled results from 8 phase III clinical trials. Gardiner D; Dukart G; Cooper A; Babinchak T Clin Infect Dis; 2010 Jan; 50(2):229-38. PubMed ID: 20025527 [TBL] [Abstract][Full Text] [Related]
43. Tigecycline treatment experience against multidrug-resistant Acinetobacter baumannii infections: a systematic review and meta-analysis. Ni W; Han Y; Zhao J; Wei C; Cui J; Wang R; Liu Y Int J Antimicrob Agents; 2016 Feb; 47(2):107-16. PubMed ID: 26742726 [TBL] [Abstract][Full Text] [Related]
44. Pharmacokinetic and pharmacodynamic evaluation of tigecycline. Giamarellou H; Poulakou G Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1459-70. PubMed ID: 21958044 [TBL] [Abstract][Full Text] [Related]
46. Tigecycline Therapy for Nosocomial Pneumonia due to Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Who Received Inappropriate Initial Antibiotic Treatment: A Retrospective Case Study. Wu X; Zhu Y; Chen Q; Gong L; Lin J; Lv D; Feng J Biomed Res Int; 2016; 2016():8395268. PubMed ID: 28044137 [No Abstract] [Full Text] [Related]
47. All-cause mortality imbalance in the tigecycline phase 3 and 4 clinical trials. McGovern PC; Wible M; El-Tahtawy A; Biswas P; Meyer RD Int J Antimicrob Agents; 2013 May; 41(5):463-7. PubMed ID: 23537581 [TBL] [Abstract][Full Text] [Related]
48. The glycylcyclines: a comparative review with the tetracyclines. Zhanel GG; Homenuik K; Nichol K; Noreddin A; Vercaigne L; Embil J; Gin A; Karlowsky JA; Hoban DJ Drugs; 2004; 64(1):63-88. PubMed ID: 14723559 [TBL] [Abstract][Full Text] [Related]
49. Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients. Kim WY; Moon JY; Huh JW; Choi SH; Lim CM; Koh Y; Chong YP; Hong SB PLoS One; 2016; 11(3):e0150642. PubMed ID: 26934182 [TBL] [Abstract][Full Text] [Related]
50. [Tigecycline: a new antibiotic in ongoing clinical development]. Stahl JP Med Mal Infect; 2005 Feb; 35(2):62-7. PubMed ID: 15780894 [TBL] [Abstract][Full Text] [Related]